Loading market data...
Latest Top News
Astec Lifesciences Unveils ₹250 Crore Rights Issue at ₹890 Per Share—Investors Eye Revival Amid Sector Headwinds
Astec Lifesciences Ltd, a leading agrochemical manufacturer and subsidiary of Godrej Agrovet, has set the stage for a significant capital infusion by announcing a rights issue priced at ₹890 per share. The board approved raising up to ₹250 crore through this fully paid equity rights issue, aiming...
Stay Ahead – Explore Now! Apollo Hospitals Board Proposes Independent Listing of Apollo Healthtech






